These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26389778)

  • 1. Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer.
    Kaira K; Naruse I; Imai H; Sunaga N; Hisada T; Motegi M; Asao T; Yamada M
    Chemotherapy; 2014; 60(5-6):356-9. PubMed ID: 26389778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful S-1 monotherapy for chemorefractory thymic carcinoma.
    Koizumi T; Agatsuma T; Komatsu Y; Kubo K
    Anticancer Res; 2011 Jan; 31(1):299-301. PubMed ID: 21273614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-1 treatment for chemorefractory thymic carcinoma.
    Ono A; Naito T; Yamamoto N
    J Thorac Oncol; 2008 Sep; 3(9):1076. PubMed ID: 18758317
    [No Abstract]   [Full Text] [Related]  

  • 4. [A Recurrent Case of Thymic Adenocarcinoma Effectively Treated with S-1 Over a Long-Term Period].
    Takata M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Tamura M; Takemura H; Ikeda H
    Gan To Kagaku Ryoho; 2017 Mar; 44(3):239-242. PubMed ID: 28292994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.
    Okuma Y; Hosomi Y; Miyamoto S; Shibuya M; Okamura T; Hishima T
    BMC Cancer; 2016 Feb; 16():156. PubMed ID: 26915359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of advanced gastric cancer treated with S-1 and S-1/paclitaxel showing complete response twice].
    Matsuyama J; Naitou A; Hiraki M; Matsumoto S; Hashimoto K; Yokoyama S; Morita S; Morimoto T; Fukushima Y; Nishishou I; Nomura T; Sasaki Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2297-9. PubMed ID: 20037401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-1 is an active anticancer agent for advanced thymic carcinoma.
    Okuma Y; Shimokawa T; Takagi Y; Hosomi Y; Iguchi M; Okamura T; Shibuya M
    Lung Cancer; 2010 Dec; 70(3):357-63. PubMed ID: 20951466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case responding to weekly paclitaxel therapy as second-line chemotherapy for gastric cancer previously treated with TS-1].
    Imamura H; Furukawa H; Kishi K; Tatsuta M; Masutani S; Fukunaga M; Nakayama T; Shimizu J; Takemoto H; Kishimoto T; Kato H; Yamamoto K; Fujishima M; Kawasaki T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1693-5. PubMed ID: 15553685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of postoperative gastric cancer responding to adjuvant chemotherapy with TS-1--a novel oral formation of 5-fluorouracil].
    Yamada T; Morishita M; Yoshida K; Kinoshita S; Yokoi K; Nakamura M; Morita K; Harada T; Yagi S; Kitagawa S; Nakagawa M
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1909-12. PubMed ID: 11729486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1].
    Iguchi H; Hashimoto K; Sunami K; Takayama M; Nakamura A; Yamane H
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):101-4. PubMed ID: 12557712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of multiple metastases breast cancer controlled using S-1 as third-line chemotherapy].
    Nakajima F; Matsuoka K; Ogawa T; Nomura H; Araya J
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1163-5. PubMed ID: 21772103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of advanced gastric cancer resistant to S-1 successfully treated with weekly administration of paclitaxel].
    Yabe N; Murai S; Akatsu T; Shoji T; Shimizu H; Fukushima H; Mitsugi Y; Ishida T; Amemiya T; Hasegawa H; Kitagawa Y
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2439-41. PubMed ID: 21224599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case reports of use of TS-1 for second/third-line chemotherapy for advanced colorectal carcinoma].
    Kabeshima Y; Takahashi Y; Kameyama N; Toizumi A; Tamura Y; Kageyama T
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):873-5. PubMed ID: 15984535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-1 monotherapy in patients with advanced biliary tract cancer.
    Sasaki T; Isayama H; Yashima Y; Yagioka H; Kogure H; Arizumi T; Togawa O; Matsubara S; Ito Y; Nakai Y; Sasahira N; Hirano K; Tsujino T; Tada M; Kawabe T; Omata M
    Oncology; 2009; 77(1):71-4. PubMed ID: 19556812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of advanced gastric cancer with histological complete response after S-1 chemotherapy].
    Yahara N; Hayashi H; Furuya T; Saeki T; Hayashi H; Inoue Y; Yanai H; Ishigaki N
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2300-2. PubMed ID: 20037402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Carcinosarcoma of the Esophagus Treated with Chemoradiotherapy].
    Nakao E; Iijima S; Tsujimura N; Matsumoto T; Takemoto H; Takachi K; Nishioka K; Oshima S; Uemura Y; Yoshida K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1905-7. PubMed ID: 26805212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term complete response to treatment with TS-1 in a patient with oropharyngeal squamous cell carcinoma].
    Homma A; Suzuki F; Oridate N; Furuta Y; Inuyama Y; Fukuda S
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1475-8. PubMed ID: 12214481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report of advanced cardiac cancer showing a complete response to TS-1 as neoadjuvant chemotherapy].
    Yamamoto Y; Kino Y; Ohara K; Onuma S; Asai K; Kobayashi T; Kono T; Kasai S
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):579-83. PubMed ID: 15114703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of S-1-based chemotherapy for platinum (and antrathycline)-refractory advanced thymic carcinoma.
    Hirai F; Seto T; Inamasu E; Toyokawa G; Yoshida T; Nosaki K; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
    Anticancer Res; 2014 Oct; 34(10):5743-7. PubMed ID: 25275083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.
    Koizumi W; Narahara H; Hara T; Takagane A; Akiya T; Takagi M; Miyashita K; Nishizaki T; Kobayashi O; Takiyama W; Toh Y; Nagaie T; Takagi S; Yamamura Y; Yanaoka K; Orita H; Takeuchi M
    Lancet Oncol; 2008 Mar; 9(3):215-21. PubMed ID: 18282805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.